相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tissue Determinants of Human NK Cell Development, Function, and Residence
Pranay Dogra et al.
CELL (2020)
NK Cell-Based Immunotherapy in Renal Cell Carcinoma
Inigo Terren et al.
CANCERS (2020)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
Joseph Cursons et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention
Rosa Molfetta et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Brian Rini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Human M2 Macrophages Limit NK Cell Effector Functions through Secretion of TGF-β and Engagement of CD85j
Sol Y. Nunez et al.
JOURNAL OF IMMUNOLOGY (2018)
NKG2D-MICA Interaction: A Paradigm Shift in Innate Recognition
Mathieu Blery et al.
JOURNAL OF IMMUNOLOGY (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
The function and dysfunction of memory CD8+ T cells in tumor immunity
James L. Reading et al.
IMMUNOLOGICAL REVIEWS (2018)
The Broad Spectrum of Human Natural Killer Cell Diversity
Aharon G. Freud et al.
IMMUNITY (2017)
Targeted therapies for renal cell carcinoma
Edwin M. Posadas et al.
NATURE REVIEWS NEPHROLOGY (2017)
Diversity of tissue-resident NK cells
Hui Peng et al.
SEMINARS IN IMMUNOLOGY (2017)
Negatively regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway
Yang Xia et al.
ONCOTARGET (2017)
Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries
Martin C. S. Wong et al.
SCIENTIFIC REPORTS (2017)
Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4
Nathalie Rouas-Freiss et al.
ONCOIMMUNOLOGY (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Stephane Chevrier et al.
CELL (2017)
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Jose Luis Perez-Gracia et al.
CANCER TREATMENT REVIEWS (2017)
Human CD56bright NK Cells: An Update
Tatiana Michel et al.
JOURNAL OF IMMUNOLOGY (2016)
missMDA: A Package for Handling Missing Values in Multivariate Data Analysis
Julie Josse et al.
Journal of Statistical Software (2016)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
Asma Beldi-Ferchiou et al.
ONCOTARGET (2016)
Modulation of natural killer cell functions by interactions between 2B4 and CD48 in cis and in trans
Maren Claus et al.
OPEN BIOLOGY (2016)
Underground Adaptation to a Hostile environment: Acute Myeloid Leukemia vs. Natural Killer Cells
Nicolas Dulphy et al.
FRONTIERS IN IMMUNOLOGY (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade
Maria P. Roberti et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness
Andrea Ziblat et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention
Petra U. Prinz et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
Alexander W. MacFarlane et al.
CANCER IMMUNOLOGY RESEARCH (2014)
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
Rizwan Romee et al.
BLOOD (2013)
Functional significance of CD57 expression on human NK cells and relevance to disease
Carolyn M. Nielsen et al.
FRONTIERS IN IMMUNOLOGY (2013)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Organ-specific features of natural killer cells
Fu-Dong Shi et al.
NATURE REVIEWS IMMUNOLOGY (2011)
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells
Kerstin Juelke et al.
BLOOD (2010)
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
Sandra Lopez-Verges et al.
BLOOD (2010)
The Association of MHC Class I Proteins with the 2B4 Receptor Inhibits Self-Killing of Human NK Cells
Gili Betser-Cohen et al.
JOURNAL OF IMMUNOLOGY (2010)
HLA class I molecules regulate IFN-γ production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j
Esther Morel et al.
JOURNAL OF IMMUNOLOGY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
NK cells at the interface between innate and adaptive immunity
A. Moretta et al.
CELL DEATH AND DIFFERENTIATION (2008)
NK cell regulation by SLAM family receptors and SAP-related adapters
Andre Veillette
IMMUNOLOGICAL REVIEWS (2006)
Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma
JS Schleypen et al.
CLINICAL CANCER RESEARCH (2006)
Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244)
P Eissmann et al.
BLOOD (2005)
Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines
G Rubio et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes
JS Schleypen et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
